Toll-Like Receptors: Cost or Benefit for Cancer?

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|16|9|1081-1090

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.9, 2010-03, pp. : 1081-1090

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inflammatory and Non-Inflammatory Roles for Toll-Like Receptors in Gastrointestinal Cancer

By  

Current Pharmaceutical Design, Vol. 21, Iss. 21, 2015-06 ,pp. : 2968-2977

Bentham Science Publishers

Access to resources Recommend Favorite

Toll-Like Receptors and Kidney Diseases

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 8, Iss. 3, 2009-07 ,pp. : 191-201

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Toll-like Receptors in Autoimmunity

By  

Current Drug Targets, Vol. 10, Iss. 11, 2009-11 ,pp. : 1139-1155

Bentham Science Publishers

Access to resources Recommend Favorite

The Toll-like receptors and their role in septic shock

By Cristofaro Patricia   Opal Steven M  

Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 5, 2003-10 ,pp. : 603-612

Informa Healthcare

Access to resources Recommend Favorite

Toll-like receptors as therapeutic targets in gastrointestinal diseases

By Pimentel-Nunes Pedro   Soares João Bruno   Roncon-Albuquerque Jr Roberto   Dinis-Ribeiro Mário   Leite-Moreira Adelino F  

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 4, 2010-04 ,pp. : 347-368

Informa Healthcare

Access to resources Recommend Favorite